The global migraine drugs market size was valued at USD 4.8 billion in 2021 and is poised to grow at a significant CAGR of 8.4% during the forecast period 2022-28. Migraine is a neurological illness that causes throbbing ache in the forehead, side of the head, or around the eyes in one person only. Autonomic symptoms such as nausea, vertigo, photophobia, and phonophobia are frequently...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian